Moonlake Immunotherapeutics $11.47 (-0.31, 2.63%)

NASDAQ
97% success, from Analysis 7* of this Model (*Public)
Summary
SHORTSELL: Best moves 24 which gains 579.68, return on capital invested 34.33%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action